New research reveals a simple urine test using nanopore sequencing for detecting early-stage ovarian cancer.

New research promises a simple urine test in detecting early-stage ovarian cancer, marking a potential breakthrough in screening for the often overlooked disease. Previous studies have indicated the presence of specific peptides in the urine of individuals with ovarian cancer, but the methods used to detect these biomarkers have been complex and costly. A professor at Virginia Commonwealth University has found that nanopore sequencing, a technique that reads genetic material by passing it through a tiny hole and monitoring electric current fluctuations, could be applied to detect these peptides simultaneously, and therefore more efficiently.

February 12, 2024
5 Articles